Viral and cellular determinants of apoptosis induced by mammalian reovirus

International Reviews of Immunology

Volumn 22, Issue 5-6, 2003, Pages 477-503

  O'Donnell, Sean M ^a   Hansberger, Mark W ^a   Dermody, Terence S ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Encephalitis; JAM1; NF B; Reovirus

Indexed keywords

CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JUNCTIONAL ADHESION MOLECULE A; MEMBRANE PROTEIN; SIALIC ACID; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DEATH; NONHUMAN; PROTEIN TRANSPORT; RECEPTOR BINDING; REOVIRUS; REVIEW; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS ISOLATION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; APOPTOSIS; CASPASES; HUMANS; MICE; MODELS, BIOLOGICAL; NF-KAPPA B; PROTEIN CONFORMATION; REOVIRIDAE; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0141928535     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.1080/08830180305212     Document Type: Review

References (114)

1. Y. Shen and T.E. Shenk, Viruses and apoptosis, Curr. Opin. Genet. Devel., 5: 105-111, 1995.
2. V. O'Brien, Viruses and apoptosis, J. Gen. Virol., 79: 1833-1845, 1998.
3. A. Ashkenazi and V.M. Dixit, Death receptors: Signaling and modulation, Science, 281: 1305-1308, 1998.
4. A.H. Wyllie, Apoptosis: An overview, Br. Med. Bull., 53: 451-465, 1997.
5. E.S. Razvi and R.M. Welsh, Apoptosis in viral infections, Adv. Virus Res., 45: 1-60, 1995.
6. J.G. Teodoro and P.E. Branton, Regulation of apoptosis by viral gene products, J. Virol, 71: 1739-1746, 1997.
7. A. Roulston, R.C. Marcellus, and P.E. Branton, Viruses and apoptosis, Ann. Rev. Microbiol, 53: 577-628, 1999.
8. E.M. Schwarz, C. Badorff, T.S. Hiura, R. Wessely, B. Badorff, I.M. Verma, and K.U. Knowlton, NF-kappaB-mediated inhibition of apoptosis is required for encephalomyocarditis virus virulence: A mechanism of resistance in p50 knockout mice, J. Virol., 72: 5654-5660, 1998.
9. J.J. Cohen, Programmed cell death in the immune system, Adv. Immunol., 50: 55-85, 1991.
10. M.L. Nibert and L.A. Schiff, In: D.M. Knipe and P.M. Howley (Eds.), Fields Virology, Philadelphia: Lippincott-Raven, pp. 1679-1728, 2001.
11. K.L. Tyler, In: D.M. Knipe and P.M. Howley (Eds.), Fields Virology, Philadelphia: Lippincott-Raven, pp. 1729-1945, 2001.
12. A.B. Sabin, Reoviruses: A new group of respiratory and enteric viruses formerly classified as ECHO type 10 is described. Science, 130: 1387-1389, 1959.
13. L. Rosen, In: E.H. Lennette and N.J. Schmidt (Eds.), Diagnostic Procedures for Viral and Rickettsial Infections, New York: American Public Health Association, pp. 577-584, 1979.
14. K.A. Dryden, G. Wang, M. Yeager, M.L. Nibert, K.M. Coombs, D.B. Furlong, B.N. Fields, and T.S. Baker, Early steps in reovirus infection are associated with dramatic changes in supramolecular structure and protein conformation: Analysis of virions and subviral particles by cryoelectron microscopy and image reconstruction, J. Cell Biol., 122: 1023-1041, 1993.
15. K.M. Coombs, Stoichiometry of reovirus structural proteins in virus, ISVP, and core particles, Virology, 243: 218-228, 1998.
16. K.M. Reinisch, M.L. Nibert, and S.C. Harrison, Structure of the reovirus core at 3.6 Å resolution, Nature, 404: 960-967, 2000.
17. D.B. Furlong, M.L. Nibert, and B.N. Fields, Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles. J. Virol., 62: 246-256, 1988.
18. R.D.B. Fraser, D.B. Furlong, B.L. Trus, M.L. Nibert, B.N. Fields, and A.C. Steven, Molecular structure of the cell-attachment protein of reovirus: Correlation of computer-processed electron micrographs with sequence-based predictions, J. Virol., 64: 2990-3000, 1990.
19. J.D. Chappell, A. Prota, T.S. Dermody, and T. Stehle, Crystal structure of reovirus attachment protein s1 reveals evolutionary relationship to adenovirus fiber, EMBO J., 21: 1-11, 2002.
20. E.S. Barton, J.C. Forrest, J.L. Connolly, J.D. Chappell, Y. Liu, E. Schnell, A. Nusrat, C.A. Parkos and T.S. Dermody, Junction adhesion molecule is a receptor for reovirus, Cell, 104: 441-451, 2001.
21. L.J. Sturzenbecker, M.L. Nibert, D.B. Furlong, and B.N. Fields, Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle, J. Virol., 61: 2351-2361, 1987.
22. J. Borsa, M.D. Sargent, P.A. Lievaart, and T.P. Copps, Reovirus: Evidence for a second step in the intracellular uncoating and transcriptase activation process, Virology, 111: 191-200, 1981.
23. D.H. Rubin, D.B. Weiner, C. Dworkin, M.I. Greene, G.G. Maul, and W.V. Williams, Receptor utilization by reovirus type 3: Distinct binding sites on thymoma and fibroblast cell lines result in differential compartmentalization of virions, Microb. Pathog., 12: 351-365, 1992.
24. G.S. Baer, D.H. Ebert, C.J. Chung, A.H. Erickson, and T.S. Dermody, Mutant cells selected during persistent reovirus infection do not express mature cathepsin L and do not support reovirus disassembly, J. Virol., 73: 9532-9543, 1999.
25. J.W. Hooper and B.N. Fields, Monoclonal antibodies to reovirus s1 and m1 proteins inhibit chromium release from mouse L cells, J. Virol., 70: 672-677, 1996.
26. P. Lucia-Jandris, J.W. Hooper and B.N. Fields, Reovirus M2 gene is associated with chromium release from mouse L cells, J. Virol., 67: 5339-5345, 1993.
27. J.W. Hooper and B.N. Fields, Role of the μ1 protein in reovirus stability and capacity to cause chromium release from host cells, J. Virol., 70: 459-467, 1996.
28. M.Schonberg, S.C. Silverstein, D.H. Levin, and G. Acs, Asynchronous synthesis of the complementary strands of the reovirus genome, Proc. Natl. Acad. Sci. USA, 68: 505-508, 1971.
29. J.K.-K. Li, J.D. Keene, P.P. Scheible, and W.K. Joklik, Nature of the 3′-terminal sequence of the plus and minus strands of the S1 gene of reovirus serotypes 1, 2, and 3, Virology, 105: 41-51, 1980.
30. E.M. Morgan and H.J. Zweerink, Characterization of transcriptase and replicase particles isolated from reovirus infected cells, Virology, 68: 455-466, 1975.
31. W.K. Joklik, Structure and function of the reovirus genome, Microbiol. Rev., 45: 483-501, 1981.
32. H.W. Virgin, K.L. Tyler, and T.S. Dermody, In: N. Nathanson (Ed.), Viral Pathogenesis, New York: Lippincott-Raven, pp. 669-699, 1997.
33. J.L. Wolf, D.H. Rubin, R. Finberg, R.S. Kaufman, A.H. Sharpe, J.S. Trier, and B.N. Fields, Intestinal M cells: A pathway of entry of reovirus into the host, Science, 212: 471-472, 1981.
34. K.L. Tyler, D.A. McPhee, and B.N. Fields, Distinct pathways of viral spread in the host determined by reovirus S1 gene segment, Science, 233: 770-774, 1986.
35. H.L. Weiner, M.L. Powers, and B.N. Fields, Absolute linkage of virulence and central nervous system tropism of reoviruses to viral hemagglutinin, J. Infect. Dis., 141: 609-616, 1980.
36. H.L. Weiner, D. Drayna, D.R. Averill, Jr. and B.N. Fields, Molecular basis of reovirus virulence: Role of the S1 gene, Proc. Natl. Acad. Sci. USA., 74: 5744-5748, 1977.
37. L.A. Morrison, R.L. Sidman, and B.N. Fields, Direct spread of reovirus from the intestinal lumen to the central nervous system through vagal autonomic nerve fibers, Proc. Natl. Acad. Sci. USA., 88: 3852-3856, 1991.
38. M. Tardieu, M.L. Powers, and H.L. Weiner, Age-dependent susceptibility to reovirus type 3 encephalitis: Role of viral and host factors, Ann. Neurol., 13: 602-607, 1983.
39. M. A. Dichter and H.L. Weiner, Infection of neuronal cell cultures with reovirus mimics in vitro patterns of neurotropism, Ann. Neurol., 16: 603-610, 1984.
40. H.L. Weiner, K.A. Ault, and B.N. Fields, Interaction of reovirus with cell surface receptors. I. Murine and human lymphocytes have a receptor for the hemagglutinin of reovirus type 3, J. Immunol., 124: 2143-2148, 1980.
41. P.W. Lee, E.C. Hayes, and W.K. Joklik, Protein σ1 is the reovirus cell attachment protein, Virology, 108: 156-163, 1981.
42. K.L. Tyler, M.K. Squier, S.E. Rodgers, S.E. Schneider, S.M. Oberhaus, T.A. Grdina, J.J. Cohen, and T.S. Dermody, Differences in the capacity of reovirus strains to induce apoptosis are determined by the viral attachment protein σ1, J. Virol., 69: 6972-6979, 1995.
43. S.E. Rodgers, E.S. Barton, S.M. Oberhaus, B. Pike, C.A. Gibson, K.L. Tyler, and T.S. Dermody, Reovirus-induced apoptosis of MDCK cells is not linked to viral yield and is blocked by Bcl-2, J. Virol., 71: 2540-2546, 1997.
44. P. Clarke, S.M. Meintzer, S. Gibson, C. Widmann, T.P. Garrington, G.L. Johnson, and K.L. Tyler, Reovirus-induced apoptosis is mediated by TRAIL, J. Virol., 74: 8135-8139, 2000.
45. J.L. Connolly, S.E. Rodgers, P. Clarke, D.W. Ballard, L.D. Kerr, K.L. Tyler, and T.S. Dermody, Reovirus-induced apoptosis requires activation of transcription factor NF-κB, J. Virol., 74: 2981-2989, 2000.
46. S.M. Oberhaus, R.L. Smith, G.H. Clayton, T.S. Dermody, and K.L. Tyler, Reovirus infection and tissue injury in the mouse central nervous system are associated with apoptosis, J. Virol., 71: 2100-2106, 1997.
47. R. DeBiasi, C. Edelstein, B. Sherry, and K. Tyler, Calpain inhibition protects against virus-induced apoptotic myocardial injury, J. Virol., 75: 351-361, 2001.
48. J.L. Connolly, E.S. Barton, and T.S. Dermody, Reovirus binding to cell surface sialic acid potentiates virus-induced apoptosis, J. Virol., 75: 4029-4039, 2001.
49. K.L. Tyler, M.K.T. Squier, A.L. Brown, B. Pike, D. Willis, S.M. Oberhaus, T.S. Dermody, and J.J. Cohen, Linkage between reovirus-induced apoptosis and inhibition of cellular DNA synthesis: Role of the S1 and M2 genes. J. Virol., 70: 7984-7991, 1996.
50. H. Ernst and A.J. Shatkin, Reovirus hemagglutinin mRNA codes for two polypeptides in overlapping reading frames, Proc. Natl. Acad. Sci. USA., 82: 48-52, 1985.
51. B.L. Jacobs, J.A. Atwater, S.M. Munemitsu, and C.E. Samuel, Biosynthesis of reovirus-specified polypeptides. The S1 mRNA synthesized in vivo is structurally and functionally indistinguishable from in vitro-synthesized S1 mRNA and encodes two polypeptides, σ1a and σ1bNS, Virology, 147: 9-18, 1985.
52. G. Sarkar, J. Pelletier, R. Bassel-Duby, A. Jayasuriya, B.N. Fields, and N. Sonenberg, Identification of a new polypeptide coded by reovirus gene S1, J. Virol., 54: 720-725, 1985.
53. S.E. Rodgers, J.L. Connolly, J.D. Chappell, and T.S. Dermody, Reovirus growth in cell culture does not require the full complement of viral proteins: Identification of a σ1s-null mutant. J. Virol., 72: 8597-8604, 1998.
54. S.J. Burstin, D.R. Spriggs, and B.N. Fields, Evidence for functional domains on the reovirus type 3 hemagglutinin, Virology, 117: 146-155, 1982.
55. P.W.K. Lee, E.C. Hayes, and W.K. Joklik, Characterization of anti-reovirus immunoglobulins secreted by cloned hybridoma cell lines, Virology, 108: 134-146, 1981.
56. H.L. Weiner and B.N. Fields, Neutralization of reovirus: The gene responsible for the neutralization antigen, J. Exp. Med., 146: 1305-1310, 1977.
57. M.A. McCrae and W.K. Joklik, The nature of the polypeptide encoded by each of the ten double-stranded RNA segments of reovirus type 3, Virology, 89: 578-593, 1978.
58. T.A. Mustoe, R.F. Ramig, A.H. Sharpe, and B.N. Fields, Genetics of reovirus: Identification of the dsRNA segments encoding the polypeptides of the μ and σ size classes, Virology, 89: 594-604, 1978.
59. M.L. Nibert, L.A. Schiff, and B.N. Fields, Mammalian reoviruses contain a myristoylated structural protein, J. Virol., 65: 1960-1967, 1991.
60. G.S. Baer and T.S. Dermody, Mutations in reovirus outer-capsid protein σ3 selected during persistent infections of L cells confer resistance to protease inhibitor E64, J. Virol., 71: 4921-4928, 1997.
61. J.D. Chappell, V.L. Gunn, J.D. Wetzel, G.S. Baer, and T.S. Dermody, Mutations in type 3 reovirus that determine binding to sialic acid are contained in the fibrous tail domain of viral attachment protein σ1, J. Virol., 71: 1834-1841, 1997.
62. J.D. Chappell, J.L. Duong, B.W. Wright, and T.S. Dermody, Identification of carbohydrate-binding domains in the attachment proteins of type 1 and type 3 reoviruses, J. Virol., 74: 8472-8479, 2000.
63. E.S. Barton, J.L. Connolly, J.C. Forrest, J.D. Chappell, and T.S. Dermody, Utilization of sialic acid as a coreceptor enhances reovirus attachment by multistep adhesion strengthening, J. Biol. Chem., 276: 2200-2211, 2001.
64. E.S. Barton, B.E. Youree, D.H. Ebert, J.C. Forrest, J.L. Connolly, T. Valyi-Nagy, K. Washington, J.D. Wetzel and T.S. Dermody, Utilization of sialic acid as a coreceptor is required for reovirus-induced biliary disease, J. Clin. Invest., 111: 1823-1833, 2003.
65. T.S. Dermody, M.L. Nibert, R. Bassel-Duby, and B.N. Fields, A sigma 1 region important for hemagglutination by serotype 3 reovirus strains, J. Virol., 64: 5173-5176, 1990.
66. I. Martin-Padura, S. Lostaglio, M. Schneemann, L. Williams, M. Romano, P. Fruscella, C. Panzeri, A. Stoppacciaro, L. Ruco, A. Villa, D. Simmons and E. Dejana, Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration, J. Cell Biol., 142: 117-127, 1998.
67. Y. Liu, A. Nusrat, F.J. Schnell, T.A. Reaves, S. Walsh, M. Ponchet, and C.A. Parkos, Human junction adhesion molecule regulates tight junction resealing in epithelia, J. Cell Sci., 113: 1-11, 2000.
68. G. Bazzoni, O.M. Martinez-Estrada, F. Orsenigo, M. Cordenonsi, S. Citi, and E. Dejana, Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin, J. Biol. Chem., 275:20520-20526, 2000.
69. K. Ebnet, C.U. Schulz, M.K. Meyer Zu Brickwedde, G.G. Pendl, and D. Vestweber, Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1, J. Biol. Chem., 275: 27979-27988, 2000.
70. A. Del Maschio, A. De Luigi, I. Martin-Padura, M. Brockhaus, T. Bartfai, P. Fruscella, L. Adorini, G. Martino, R. Furlan, M.G. De Simoni and E. Dejana, Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM), J. Exp. Med., 190: 1351-1356, 1999.
71. F. Lechner, U. Sahrbacher, T. Suter, K. Frei, M. Brockhaus, U. Koedel, and A. Fontana, Antibodies to the junctional adhesion molecule cause disruption of endothelial cells and do not prevent leukocyte influx into the meninges after viral or bacterial infection, J. Infect. Dis., 182: 978-982, 2000.
72. I. Martin-Padura, S. Lostaglio, M. Schneemann, L. Williams, M. Romano, P. Fruscella, C. Panzeri, A. Stoppacciaro, L. Ruco, A. Villa, D. Simmons and E. Dejana, Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration, J. Cell Biol., 142: 117-127, 1998.
73. W.M. Canning and B.N. Fields, Ammonium chloride prevents lytic growth of reovirus and helps to establish persistent infection in mouse L cells, Science, 219: 987-988, 1983.
74. D.H. Ebert, J. Deussing, C. Peters, and T.S. Dermody, L. Cathepsin, and B cathepsin, mediate reovirus disassembly in murine fibroblast cells, J. Biol. Chem., 277: 24609-24617, 2002.
75. J.L. Connolly and T.S. Dermody, Virion disassembly is required for apoptosis induced by reovirus, J. Virol., 76: 1632-1641, 2002.
76. P. Baeuerle and D. Baltimore, A 65-kD subunit of active NF-κB is required for inhibition of NF-κB by IκB. Genes Dev., 3: 1689-1698, 1989.
77. V. Palombella, O. Rando, A. Goldberg, and T. Maniatis, The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B, Cell 78: 773-785, 1994.
78. A.A. Beg, S.M. Ruben, R.I. Scheinman, S. Haskill, C.A. Rosen, and A.J. Baldwin, IκB interacts with the nuclear localization sequences of the subunits of NF-κB: A mechanism for cytoplasmic retention, Genes Dev., 6: 1899-1913, 1992.
79. C. Abbadie, N. Kabrun, F. Bouali, B. Vandenbunder, and P. Enrietto, High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro, Cell, 75: 899-912, 1993.
80. S. Grimm, M.K.A. Bauer, P.A. Baeuerle, and K. Schulze-Osthoff, Bcl-2 down-regulates the activity of transcription factor NF-κB induced upon apoptosis, J. Cell Biol., 134: 13-23, 1996.
81. M. Jung, Y. Zhang, S. Lee, and A. Dritschilo, Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated IκB-α, Science, 268: 1619-1621, 1995.
82. A. Beg and D. Baltimore, An essential role for NF-κB in preventing TNF-α-induced cell death, Science, 274: 782-784, 1996.
83. Z.-G. Liu, H. Hsu, D. Goeddel, and M. Karin, Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death, Cell, 87: 565-576, 1996.
84. D. Van Antwerp, S. Martin, T. Kafri, D. Green, and I. Verma, Suppression of TNF-α-induced apoptosis by NF-κB, Science, 274: 787-789, 1996.
85. J.T. Jan, B.H. Chen, S.H. Ma, C.I. Liu, H.P. Tsai, H.C. Wu, S.Y. Jiang, K.D. Yang and M.F. Shaio, Potential dengue virus-triggered apoptotic pathway in human neuroblastoma cells: Arachidonic acid, superoxide anion, and NF-kappaB are sequentially involved, J. Virol., 74: 8680-8691, 2000.
86. H.L. Pahl and P.A. Baeuerle, Expression of influenza virus hemagglutinin activates transcription factor NF-kappa B, J. Virol., 69: 1480-1484, 1995.
87. J.G. Mastronarde, B. He, M.M. Monick, N. Mukaida, K. Matsushima, and G.W. Hunninghake, Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)-kappa B and NF-IL-6, J. Infect. Dis., 174: 262-267, 1996.
88. K.I. Lin, S.H. Lee, R. Narayanan, J. Baraban, J. Hardwick, and R. Ratan, Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B, J. Cell Biol., 131: 1149-1161, 1995.
89. P. Marianneau, A. Cardona, L. Edelman, V. Deubel, and P. Despres, Dengue virus replication in human hepatoma cells activates NF-kappaB which in turn induces apoptotic cell death, J. Virol., 71: 3244-3249, 1997.
90. A. Beg, T. Finco, P. Nantermet, and A. Baldwin, Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: A mechanism for NF-κB activation, Molec. Cell. Biol., 13: 3301-3310, 1993.
91. S.M. Richardson-Burns, D.J. Kominsky, and K.L. Tyler, Reovirus-induced neuronal apoptosis is mediated by caspase 3 and is associated with the activation of death receptors, J. Neurovirol., 8: 365-380, 2002.
92. R. Ravi, G.C. Bedi, L.W. Engstrom, Q. Zeng, B. Mookerjee, C. Gelinas, E.J. Fuchs, and A. Bedi, Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB, Nat. Cell. Biol., 3: 409-416, 2001.
93. A.C. Spalding, R.M. Jotte, R.I. Scheinman, M.W. Geraci, P. Clarke, K.L. Tyler, and G.L. Johnson, TRAIL and inhibitors of apoptosis are opposing determinants for NF-kappaB-dependent, genotoxin-induced apoptosis of cancer cells, Oncogene, 21: 260-271, 2002.
94. I. Rivera-Walsh, M. Waterfield, G. Xiao, A. Fong, and S.C. Sun, NF-kappaB signaling pathway governs TRAIL gene expression and human T-cell leukemia virus-I Tax-induced T-cell death, J. Biol. Chem., 276: 40385-40388, 2001.
95. R.L. Debiasi, M.K.T. Squier, B. Pike, M. Wynes, T.S. Dermody, J.J. Cohen, and K.L. Tyler, Reovirus-induced apoptosis is preceded by increased cellular calpain activity and is blocked by calpain inhibitors. J. Virol., 73: 695-701, 1999.
96. M.K. Squier, A.J. Sehnert, K.S. Sellins, A.M. Malkinson, E. Takano, and J.J. Cohen, Calpain and calpastatin regulate neutrophil apoptosis, J. Cell Physiol., 178: 311-319, 1999.
97. R. Nath, K.J. Raser, D. Stafford, I. Hajimohammadreza, A. Posner, H. Allen, R.V. Talanian, P. Yuen, R.B. Gilbertsen, and K.K. Wang, Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: Contributory roles of both protease families in neuronal apoptosis, Biochem. J., 319 (Pt 3): 683-690, 1996.
98. S.J. Chen, M.E. Bradley, and T.C. Lee, Chemical hypoxia triggers apoptosis of cultured neonatal rat cardiac myocytes: Modulation by calcium-regulated proteases and protein kinases, Mol. Cell. Biochem. 178: 141-149, 1998.
99. S. Baghdiguian, M. Martin, I. Richard, F. Pons, C. Astier, N. Bourg, R.T. Hay, R. Chemaly, G. Halaby, J. Loiselet, L.V. Anderson, A. Lopez de Munain, M. Fardeau, P. Mangeat, J.S. Beckmann, and G. Lefranc, Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/ NF-kappaB pathway in limb-girdle muscular dystrophy type 2A, Nat. Med., 5: 503-511, 1999.
100. N.B. Blatt and G.D. Glick, Signaling pathways and effector mechanisms pre-programmed cell death, Bioorg. Med. Chem., 9: 1371-1384, 2001.
101. D.J. Kominsky, R.J. Bickel, and K.L. Tyler, Reovirus-induced apoptosis requires both death receptor- and mitochondrial-mediated caspase-dependent pathways of cell death, Cell Death Differ, 9: 926-933, 2002.
102. H. Wajant, F.J. Johannes, E. Haas, K. Siemienski, R. Schwenzer, G. Schubert, T. Weiss, M. Grellurich and P. Sche, Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction, Curr. Biol., 8: 113-116, 1998.
103. P. Li, D. Nijhawan, I. Budhardjo, S.M. Srinivasula, M. Ahmad, E.S. Alnemri, and X. Wang, Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade, Cell, 91: 479-489, 1997.
104. A.M. Verhagen, P.G. Ekert, M. Pakusch, J. Silke, L.M. Connolly, G.E. Reid, R.L. Moritz, R.J. Simpson, and D.L. Vaux, Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins, Cell, 102: 43-53, 2000.
105. C. Du, M. Fang, Y. Li, L. Li, and X. Wang, Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition, Cell, 102: 33-42, 2000.
106. N. Joza, S.A. Susin, E. Daugas, W.L. Stanford, S.K. Cho, C.Y. Li, T. Sasaki, A.J. Elia, H.Y. Cheng, L. Ravagnan, K.F. Ferri, N. Zamzami, A. Wakeham, R. Hakem, H. Yoshida, Y.Y. Kong, T.W. Mak, J.C. Zuniga-Pfluoker, G. Kroemer, and J.M. Penninger, Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death, Nature, 410: 549-554, 2001.
107. H. Li, H. Zhu, C.J. Xu, and J. Yuan, Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis, Cell, 94: 491-501, 1998.
108. D.J. Kominsky, R.J. Bickel, and K.L. Tyler, Reovirus-induced apoptosis requires mitochondrial release of Smac/DIABLO and involves reduction of cellular inhibitor of apoptosis protein levels, J. Virol., 76: 11414-11424, 2002.
109. X. Luo, I. Budihardjo, H. Zou, C. Slaughter, and X. Wang, Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors, Cell, 94: 481-490, 1998.
110. V.E. Centonze, Y. Chen, T.F. Severson, G.G. Borisy, and M.L. Nibert, Visualization of single reovirus particles by low-temperature, high-resolution scanning electron microscopy, J. Struct. Biol. 115: 215-225, 1995.
111. R. Bassel-Duby, A. Jayasuriya, D. Chatterjee, N. Sonenberg, J.V. Maizel, Jr., and B.N. Fields, Sequence of reovirus haemagglutinin predicts a coiled-coil structure, Nature, 315: 421-423, 1985.
112. R. Duncan, D. Horne, L.W. Cashdollar, W.K. Joklik, and P.W.K. Lee, Identification of conserved domains in the cell attachment proteins of the three serotypes of reovirus, Virology, 174, 399-409, 1990.
113. M.L. Nibert, T.S. Dermody, and B.N. Fields, Structure of the reovirus cell-attachment protein: A model for the domain organization of σ1, J. Virol., 64: 2976-2989, 1990.
114. M. Carson, Ribbon models of macromolecules, J. Molecular Graphics, 5: 103-106, 1987.